BCL2 and breast cancer: It was also reported that WT1 is required for inhibition of apoptosis in breast cancer and rhabdoid cancer by decreasing Bcl-2 mRNA and protein levels [32], [33]; however, other reports indicated that WT1 negatively regulated the Bcl-2 promoter in the prostate cell line [34].